ARTICLE | Clinical News
Alamast pemirolast ophthalmic solution regulatory update
October 4, 1999 7:00 AM UTC
The FDA granted marketing approval for Santen's Alamast mast cell stabilizing solution, which inhibits the antigen-induced release of inflammatory mediators involved in the allergic process, to preven...